Accelerating the New Era in Biomedicine
ProSTEM continues to develop facilities and competencies, collaborating with research institutes, institutions and hospitals to actively contribute to realizing "Indonesia becomes a host in its own country" regarding health independence, especially clinical applications of stem cell-based therapy, cells and their derivatives. This includes the development of laboratory processing facilities and human resource competencies to meet the needs of regenerative therapy. Supported by collaboration with educational institutions, research institutes, and hospitals, ProSTEM actively contributes to health reform, ensuring that Indonesia becomes a host in its own country for regenerative therapy services using high-quality, safe, and effective stem cells, cells, and metabolites.
Why It Must Be ProSTEM?
ProSTEM, as the most comprehensive and advanced laboratory, has obtained operational permits from the Ministry of Health of the Republic of Indonesia, Good Manufacturing Practice (CPOB) certification from the Indonesian Food and Drug Administration (BPOM), as well as ISO 9001:2015 certification for quality management. The ProSTEM Laboratory Processing, Storage, and Testing Facilities are also equipped with automated equipment to ensure consistent and high-quality results. consistent and best quality
Standard Compliant
The processing, storage, and testing procedures conducted by ProSTEM have undergone validation and qualification processes in accordance with national requirements such as operational permits and Good Manufacturing Practices (CPOB), as well as international standards such as AABB and FACT-Net Cord.
The Facility is Advanced and Sustainable
Qualified Personnel
Guaranteed Delivery
Explore the Advanced Cell Therapy Production Laboratory (ACT-PLab) ProSTEM Exclusively
